Replies to post #99154 on Ayala Pharmaceuticals Inc (ADXS)

[raja48185]

No, I meant that Amgen’s
NEO guy left the company. As Hov noted, Amgen has largely abandoned cell-based therapy approaches in general. A change in direction for them

Of course if you say so. That same NEO guy who left the company just called me and we both had a laugh about how stupid Amgen was and still is, for letting go the 'ADXS buying opportunity'.